Feb 6, 2024

MPN Hub discusses AI in the future of bone marrow histopathology

Daniel Royston

Pathology lead

MPN Hub host Daniel Royston to discuss the potential of artificial intelligence in myeloproliferative neoplasm bone marrow histopathology, emphasizing the applications to clinical trials and importance of clinical validation.

The MPN Hub invited Daniel Royston, who leads pathology at GTL, to present on the role of AI in the future of myeloproliferative neoplasm bone marrow histopathology.

MPN Hub Steering Committee members Jean-Jacques Kiladjian, Tiziano Barbui, Chloe James, and John Mascarenhas joined the discussion.

The conversaton covered the application of our quantitative analysis of bone marrow fibrosis to the zinpentraxin alfa phase II study (NCT01981850) which was recently presented in at ASH 2023.

We applaud all the work MPN Hub does to bring open-access online resources to the MPN community!